Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d’essais randomisés contrôlés
Author(s) -
Jerome Sarris,
Wolfgang Marx,
Melanie M. Ashton,
Chee H. Ng,
Nicole Leite GalvãoCoelho,
Zahra Ayati,
ZhangJin Zhang,
Siegfried Kasper,
Arun Ravindran,
Brian H. Harvey,
Adrian L. Lopresti,
David Mischoulon,
Jay D. Amsterdam,
Lakshmi N. Yatham,
Michael Berk
Publication year - 2021
Publication title -
the canadian journal of psychiatry
Language(s) - French
Resource type - Journals
SCImago Journal Rank - 1.68
H-Index - 117
eISSN - 1497-0015
pISSN - 0706-7437
DOI - 10.1177/0706743720979917
Subject(s) - meta analysis , psychiatry , medicine , randomized controlled trial , depression (economics) , major depressive disorder , anxiety , schizophrenia (object oriented programming) , medline , systematic review , traditional medicine , mood , political science , law , economics , macroeconomics
Plant-based medicines have had a long-standing history of use in psychiatric disorders. Highly quantified and standardized extracts or isolates may be termed "phytoceuticals," in a similar way that medicinal nutrients are termed as "nutraceuticals." Over the past 2 decades, several meta-analyses have examined the data for a range of plant-based medicines in the treatment of psychiatric disorders. The aim of this international project is to provide a "meta-review" of this top-tier evidence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom